MODE OF ACTION OF THE ANTIMIGRAINE DRUG SUMATRIPTAN

[1] ANTHONY M, 1969, RESEARCH CLINICAL ST, V2, P29

[2] TIME-DEPENDENT SYNERGISTIC INTERACTIONS BETWEEN THE VASODILATOR NEUROPEPTIDE, CALCITONIN GENE-RELATED PEPTIDE (CGRP) AND MEDIATORS OF INFLAMMATION [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) : 1515 - 1519

[3] THE ANTIMIGRAINE DRUG, SUMATRIPTAN (GR43175), SELECTIVELY BLOCKS NEUROGENIC PLASMA EXTRAVASATION FROM BLOOD-VESSELS IN DURA MATER [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (01) : 202 - 206

[4] FURTHER CHARACTERIZATION OF THE PUTATIVE 5-HT RECEPTOR WHICH MEDIATES BLOCKADE OF NEUROGENIC PLASMA EXTRAVASATION IN RAT DURA-MATER [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) : 1421 - 1428

[5] TREATMENT OF ACUTE MIGRAINE WITH SUBCUTANEOUS SUMATRIPTAN [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (21): : 2831 - 2835

[6] CHARACTERIZATION OF 5-HT RECEPTORS MEDIATING CONTRACTION OF CANINE AND PRIMATE BASILAR ARTERY BY USE OF GR43175, A SELECTIVE 5-HT1-LIKE RECEPTOR AGONIST [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) : 379 - 387

[7] PRESYNAPTIC INHIBITORY ACTION OF 5-HYDROXYTRYPTAMINE IN DOG ISOLATED SAPHENOUS-VEIN [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1979, 67 (02) : 247 - 254

[8] MIGRAINE PAIN ASSOCIATED WITH MIDDLE CEREBRAL-ARTERY DILATATION - REVERSAL BY SUMATRIPTAN [J]. LANCET, 1991, 338 (8758) : 13 - 17

[9] SUMATRIPTAN REVERSES THE CHANGES IN CALCITONIN GENE-RELATED PEPTIDE SEEN IN THE HEADACHE PHASE OF MIGRAINE [J]. CEPHALALGIA, 1991, 11 : 3 - 4

[10] VASOACTIVE PEPTIDE RELEASE IN THE EXTRACEREBRAL CIRCULATION OF HUMANS DURING MIGRAINE HEADACHE [J]. ANNALS OF NEUROLOGY, 1990, 28 (02) : 183 - 187

[1] ANTHONY M, 1969, RESEARCH CLINICAL ST, V2, P29

[2] TIME-DEPENDENT SYNERGISTIC INTERACTIONS BETWEEN THE VASODILATOR NEUROPEPTIDE, CALCITONIN GENE-RELATED PEPTIDE (CGRP) AND MEDIATORS OF INFLAMMATION [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) : 1515 - 1519

[3] THE ANTIMIGRAINE DRUG, SUMATRIPTAN (GR43175), SELECTIVELY BLOCKS NEUROGENIC PLASMA EXTRAVASATION FROM BLOOD-VESSELS IN DURA MATER [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (01) : 202 - 206

[4] FURTHER CHARACTERIZATION OF THE PUTATIVE 5-HT RECEPTOR WHICH MEDIATES BLOCKADE OF NEUROGENIC PLASMA EXTRAVASATION IN RAT DURA-MATER [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) : 1421 - 1428

[5] TREATMENT OF ACUTE MIGRAINE WITH SUBCUTANEOUS SUMATRIPTAN [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (21): : 2831 - 2835

[6] CHARACTERIZATION OF 5-HT RECEPTORS MEDIATING CONTRACTION OF CANINE AND PRIMATE BASILAR ARTERY BY USE OF GR43175, A SELECTIVE 5-HT1-LIKE RECEPTOR AGONIST [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) : 379 - 387

[7] PRESYNAPTIC INHIBITORY ACTION OF 5-HYDROXYTRYPTAMINE IN DOG ISOLATED SAPHENOUS-VEIN [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1979, 67 (02) : 247 - 254

[8] MIGRAINE PAIN ASSOCIATED WITH MIDDLE CEREBRAL-ARTERY DILATATION - REVERSAL BY SUMATRIPTAN [J]. LANCET, 1991, 338 (8758) : 13 - 17

[9] SUMATRIPTAN REVERSES THE CHANGES IN CALCITONIN GENE-RELATED PEPTIDE SEEN IN THE HEADACHE PHASE OF MIGRAINE [J]. CEPHALALGIA, 1991, 11 : 3 - 4

[10] VASOACTIVE PEPTIDE RELEASE IN THE EXTRACEREBRAL CIRCULATION OF HUMANS DURING MIGRAINE HEADACHE [J]. ANNALS OF NEUROLOGY, 1990, 28 (02) : 183 - 187